631.37
Netflix Inc stock is traded at $631.37, with a volume of 3.00M.
It is down -0.43% in the last 24 hours and down -6.83% over the past month.
See More
Previous Close:
$634.09
Open:
$645
24h Volume:
3.00M
Market Cap:
$276.97B
Revenue:
$36.30B
Net Income/Loss:
$7.09B
P/E Ratio:
63.01
EPS:
10.02
Net Cash Flow:
$6.82B
1W Performance:
-0.31%
1M Performance:
-6.83%
6M Performance:
+10.69%
1Y Performance:
+49.38%
Netflix Inc Stock (NFLX) Company Profile
Name
Netflix Inc
Sector
Industry
Phone
408-540-3700
Address
121 ALBRIGHT WAY, LOS GATOS
Netflix Inc Stock (NFLX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-02-24 | Reiterated | Argus | Buy |
May-28-24 | Reiterated | Evercore ISI | Outperform |
Apr-19-24 | Downgrade | Canaccord Genuity | Buy → Hold |
Apr-19-24 | Upgrade | Needham | Hold → Buy |
Apr-19-24 | Reiterated | Pivotal Research Group | Buy |
Apr-15-24 | Reiterated | Deutsche Bank | Hold |
Apr-12-24 | Reiterated | Morgan Stanley | Overweight |
Apr-12-24 | Reiterated | Piper Sandler | Neutral |
Apr-05-24 | Reiterated | Pivotal Research Group | Buy |
Mar-25-24 | Reiterated | Citigroup | Neutral |
Mar-12-24 | Reiterated | Jefferies | Buy |
Mar-11-24 | Reiterated | Oppenheimer | Outperform |
Jan-30-24 | Downgrade | Seaport Research Partners | Buy → Neutral |
Jan-25-24 | Upgrade | DZ Bank | Hold → Buy |
Jan-24-24 | Reiterated | BMO Capital Markets | Outperform |
Jan-24-24 | Reiterated | BofA Securities | Buy |
Jan-24-24 | Reiterated | Canaccord Genuity | Buy |
Jan-24-24 | Reiterated | Evercore ISI | Outperform |
Jan-24-24 | Reiterated | Goldman | Neutral |
Jan-24-24 | Reiterated | Guggenheim | Buy |
Jan-24-24 | Reiterated | JP Morgan | Overweight |
Jan-24-24 | Reiterated | KeyBanc Capital Markets | Overweight |
Jan-24-24 | Upgrade | Macquarie | Neutral → Outperform |
Jan-24-24 | Reiterated | Morgan Stanley | Overweight |
Jan-24-24 | Reiterated | Oppenheimer | Outperform |
Jan-24-24 | Reiterated | Piper Sandler | Neutral |
Jan-24-24 | Reiterated | Pivotal Research Group | Buy |
Jan-24-24 | Reiterated | Redburn Atlantic | Buy |
Jan-24-24 | Reiterated | Robert W. Baird | Outperform |
Jan-24-24 | Reiterated | TD Cowen | Outperform |
Jan-24-24 | Reiterated | UBS | Buy |
Jan-24-24 | Reiterated | Wells Fargo | Overweight |
Sep-18-23 | Reiterated | Evercore ISI | Outperform |
Aug-25-23 | Upgrade | Loop Capital | Hold → Buy |
Jul-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
Jul-17-23 | Reiterated | Deutsche Bank | Buy |
Jul-13-23 | Reiterated | JP Morgan | Overweight |
Jul-12-23 | Reiterated | UBS | Buy |
Jul-05-23 | Upgrade | Goldman | Sell → Neutral |
Jun-29-23 | Reiterated | Citigroup | Buy |
Jun-28-23 | Reiterated | Oppenheimer | Outperform |
Jun-13-23 | Reiterated | BofA Securities | Buy |
Jun-13-23 | Reiterated | Guggenheim | Buy |
Apr-19-23 | Reiterated | Deutsche Bank | Buy |
Apr-19-23 | Reiterated | JP Morgan | Overweight |
Apr-19-23 | Reiterated | Jefferies | Buy |
Apr-19-23 | Reiterated | Piper Sandler | Neutral |
Apr-19-23 | Reiterated | Pivotal Research Group | Buy |
Apr-19-23 | Reiterated | Rosenblatt | Neutral |
Apr-19-23 | Upgrade | UBS | Neutral → Buy |
Apr-11-23 | Resumed | Robert W. Baird | Neutral |
Jan-23-23 | Reiterated | Argus | Buy |
Jan-20-23 | Reiterated | Canaccord Genuity | Buy |
Jan-20-23 | Reiterated | Deutsche Bank | Buy |
Jan-20-23 | Reiterated | Evercore ISI | Outperform |
Jan-20-23 | Reiterated | Goldman | Sell |
Jan-20-23 | Reiterated | Guggenheim | Buy |
Jan-20-23 | Reiterated | Jefferies | Buy |
Jan-20-23 | Reiterated | MoffettNathanson | Market Perform |
Jan-20-23 | Reiterated | Oppenheimer | Outperform |
Jan-20-23 | Reiterated | Piper Sandler | Neutral |
Jan-20-23 | Reiterated | Pivotal Research Group | Buy |
Jan-20-23 | Reiterated | Robert W. Baird | Neutral |
Jan-20-23 | Reiterated | The Benchmark Company | Sell |
Jan-20-23 | Reiterated | Wedbush | Outperform |
Jan-20-23 | Reiterated | Wolfe Research | Outperform |
Jan-12-23 | Upgrade | Jefferies | Hold → Buy |
Jan-04-23 | Initiated | New Street | Neutral |
Dec-29-22 | Upgrade | CFRA | Sell → Buy |
Dec-14-22 | Reiterated | Jefferies | Hold |
Dec-09-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Jun-14-22 | Downgrade | The Benchmark Company | Hold → Sell |
Jun-10-22 | Downgrade | Goldman | Neutral → Sell |
May-16-22 | Upgrade | Wedbush | Neutral → Outperform |
Apr-21-22 | Downgrade | DZ Bank | Buy → Hold |
Apr-21-22 | Downgrade | Edward Jones | Buy → Hold |
Apr-20-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
Apr-20-22 | Downgrade | BofA Securities | Buy → Underperform |
Apr-20-22 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-20-22 | Upgrade | Needham | Underperform → Hold |
Apr-20-22 | Downgrade | Oppenheimer | Outperform → Perform |
Apr-20-22 | Downgrade | Piper Sandler | Overweight → Neutral |
Apr-20-22 | Downgrade | Pivotal Research Group | Buy → Sell |
Apr-20-22 | Downgrade | Stifel | Buy → Hold |
Apr-20-22 | Downgrade | UBS | Buy → Neutral |
Apr-20-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Apr-19-22 | Initiated | Rosenblatt | Neutral |
Mar-09-22 | Upgrade | Wedbush | Underperform → Neutral |
Jan-31-22 | Upgrade | Citigroup | Neutral → Buy |
Jan-31-22 | Upgrade | Edward Jones | Hold → Buy |
Jan-24-22 | Downgrade | Jefferies | Buy → Hold |
Jan-21-22 | Reiterated | BMO Capital Markets | Outperform |
Jan-21-22 | Reiterated | BofA Securities | Buy |
Jan-21-22 | Reiterated | Canaccord Genuity | Buy |
Jan-21-22 | Reiterated | Cowen | Outperform |
Jan-21-22 | Reiterated | Deutsche Bank | Hold |
Jan-21-22 | Reiterated | Goldman | Neutral |
Jan-21-22 | Reiterated | Guggenheim | Buy |
Jan-21-22 | Reiterated | JP Morgan | Overweight |
Jan-21-22 | Reiterated | MoffettNathanson | Neutral |
Jan-21-22 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
Jan-21-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jan-21-22 | Reiterated | Oppenheimer | Outperform |
Jan-21-22 | Reiterated | Piper Sandler | Overweight |
Jan-21-22 | Reiterated | Pivotal Research Group | Buy |
Jan-21-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
Jan-21-22 | Reiterated | Stifel | Buy |
Jan-21-22 | Upgrade | The Benchmark Company | Sell → Hold |
Jan-21-22 | Downgrade | Truist | Buy → Hold |
Jan-21-22 | Reiterated | UBS | Buy |
Jan-21-22 | Reiterated | Wolfe Research | Outperform |
Dec-15-21 | Reiterated | The Benchmark Company | Sell |
Oct-20-21 | Downgrade | Deutsche Bank | Buy → Hold |
Oct-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
Sep-29-21 | Reiterated | The Benchmark Company | Sell |
Sep-13-21 | Initiated | Goldman | Neutral |
Sep-08-21 | Reiterated | JP Morgan | Overweight |
Sep-07-21 | Reiterated | Atlantic Equities | Overweight |
Jul-21-21 | Reiterated | Credit Suisse | Outperform |
Jul-21-21 | Reiterated | Deutsche Bank | Buy |
Jul-21-21 | Reiterated | JP Morgan | Overweight |
Jul-21-21 | Reiterated | KeyBanc Capital Markets | Overweight |
Jul-21-21 | Reiterated | Stifel | Buy |
Jun-25-21 | Upgrade | Credit Suisse | Neutral → Outperform |
Jun-25-21 | Initiated | Edward Jones | Hold |
May-19-21 | Resumed | Jefferies | Buy |
Apr-21-21 | Resumed | Oppenheimer | Outperform |
Apr-21-21 | Reiterated | Pivotal Research Group | Buy |
Apr-21-21 | Upgrade | Stifel | Hold → Buy |
Apr-06-21 | Resumed | Evercore ISI | Outperform |
Apr-01-21 | Initiated | Piper Sandler | Overweight |
Mar-25-21 | Reiterated | The Benchmark Company | Sell |
Mar-23-21 | Upgrade | Argus | Hold → Buy |
Jan-21-21 | Upgrade | DZ Bank | Hold → Buy |
Jan-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
Jan-20-21 | Reiterated | Pivotal Research Group | Buy |
Jan-20-21 | Reiterated | The Benchmark Company | Sell |
Jan-20-21 | Upgrade | UBS | Neutral → Buy |
Jan-20-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Oct-21-20 | Reiterated | BMO Capital Markets | Outperform |
Oct-21-20 | Reiterated | Bernstein | Outperform |
Oct-21-20 | Reiterated | Jefferies | Buy |
Oct-21-20 | Reiterated | Morgan Stanley | Overweight |
Oct-21-20 | Reiterated | Oppenheimer | Outperform |
Oct-21-20 | Reiterated | Piper Sandler | Overweight |
Oct-21-20 | Reiterated | Pivotal Research Group | Buy |
Oct-21-20 | Reiterated | RBC Capital Mkts | Outperform |
Oct-21-20 | Reiterated | The Benchmark Company | Sell |
Oct-21-20 | Reiterated | Wedbush | Underperform |
Oct-21-20 | Reiterated | Wells Fargo | Equal Weight |
Oct-16-20 | Reiterated | Morgan Stanley | Overweight |
Oct-15-20 | Reiterated | Canaccord Genuity | Buy |
Oct-14-20 | Reiterated | Goldman | Buy |
Oct-07-20 | Reiterated | Pivotal Research Group | Buy |
Sep-28-20 | Reiterated | The Benchmark Company | Sell |
Sep-15-20 | Initiated | KeyBanc Capital Markets | Overweight |
Sep-09-20 | Resumed | Raymond James | Mkt Perform |
Sep-04-20 | Reiterated | The Benchmark Company | Sell |
Jul-29-20 | Reiterated | Loop Capital | Buy |
View All
Netflix Inc Stock (NFLX) Latest News
Netflix Stock Plunged After $7M Donation to Harris Campaign? - Snopes.com
Snopes.com
Did Netflix Donate $7M to Kamala Harris' Campaign? - Snopes.com
Snopes.com
Netflix Co-Founder Reed Hastings Gifts $500 Million in Stock to Silicon Valley Charity Group - Media Play News
Media Play News
Who Owns Netflix? Largest Shareholders - The Motley Fool
The Motley Fool
Reed Hastings Gives Netflix Shares Worth $500 Million as a Gift to Silicon Valley Community Foundation - Variety
Variety
Netflix Inc. stock underperforms Friday when compared to competitors - MarketWatch
MarketWatch
Netflix Inc Stock (NFLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Netflix Inc Stock (NFLX) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
HASTINGS REED | Executive Chairman |
Jul 01 '24 |
Option Exercise |
55.49 |
22,526 |
1,249,902 |
22,583 |
HASTINGS REED | Executive Chairman |
Jul 01 '24 |
Sale |
670.49 |
22,526 |
15,103,432 |
57 |
Peters Gregory K | Co-CEO |
Jun 14 '24 |
Option Exercise |
142.65 |
4,783 |
682,295 |
17,873 |
Peters Gregory K | Co-CEO |
Jun 14 '24 |
Sale |
675.00 |
4,783 |
3,228,525 |
13,090 |
HASTINGS REED | Executive Chairman |
Jun 03 '24 |
Option Exercise |
62.69 |
19,943 |
1,250,141 |
20,000 |
HASTINGS REED | Executive Chairman |
Jun 03 '24 |
Sale |
633.58 |
19,943 |
12,635,514 |
57 |
Peters Gregory K | Co-CEO |
May 21 '24 |
Option Exercise |
140.78 |
4,846 |
682,220 |
17,936 |
Peters Gregory K | Co-CEO |
May 21 '24 |
Sale |
650.00 |
4,846 |
3,149,900 |
13,090 |
Neumann Spencer Adam | Chief Financial Officer |
May 09 '24 |
Sale |
613.08 |
564 |
345,777 |
0 |
Sweeney Anne M | Director |
May 03 '24 |
Option Exercise |
268.34 |
3,029 |
812,808 |
3,029 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):